DB15657ExperimentalProtein Based Therapies
Ala-geninthiocin is a novel thiopeptide antibacterial compound derived from marine Streptomyces species. It has exhibited potent in vitro activity against gram-positive bacteria including Staphylococcus aureus, Bacillus subtilis, Mycobacterium smegmatis, and...
What you can answer from here — as of August 31, 2026
Which companies are running trials of Ala-geninthiocin, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account